General Anesthesia Medications 2025

•  General anesthesia involves analgesia, amnesia, areflexia, and unconsciousness to ensure patient immobility and comfort during surgery.

• Anesthetic plans are customized based on surgery type, duration, and patient-specific factors such as age and comorbidities.

• Induction medications include midazolam for anxiety and memory loss, fentanyl for pain control and sympathetic suppression, and propofol as the primary anesthetic agent.

• Paralytics such as succinylcholine and rocuronium facilitate intubation by relaxing muscles.

• 🌬 Maintenance anesthesia is often managed with volatile agents like sevoflurane or isoflurane, or intravenous propofol infusions.

• Emergence medications include reversal agents, sugammadex and neostigmine (paired with glycopyrrolate), to safely reverse paralysis, plus ondansetron to minimize nausea.

• Careful consideration is necessary regarding side effects and drug interactions, such as sugammadex’s effect on hormonal birth control and ondansetron’s potential for QT prolongation.

• Holistic Anesthesia Planning: We underscore that anesthesia is not a “one-size-fits-all” procedure but a complex, individualized process. Factors such as the type and length of surgery, patient health status, and expected physiological changes guide drug selection and dosing. This personalization ensures patient safety and optimal outcomes.

• Balanced Pharmacologic Components: The four pillars of anesthesia, analgesia, amnesia, areflexia, and unconsciousness, require precise pharmacologic targeting. Midazolam’s anxiolytic and amnestic effects prepare the patient psychologically, while fentanyl and other opioids manage nociceptive pain and sympathetic responses, demonstrating the integration of central nervous system and peripheral effects.

• Role of Propofol and Vasopressors: Propofol’s widespread use for induction and maintenance is balanced by its vasodilatory effects, which risk hypotension. The ready availability of vasopressors like phenylephrine and ephedrine highlights the need for vigilant hemodynamic monitoring and rapid intervention to maintain stable blood pressure during induction.

• Neuromuscular Blocking Agents: The choice between depolarizing (succinylcholine) and non-depolarizing (rocuronium) paralytics depends on desired duration and patient factors. Succinylcholine’s short action is ideal for rapid intubation, while rocuronium’s longer duration suits extended procedures. Understanding their pharmacodynamics is crucial for timing intubation and subsequent reversal.

• Emergence and Reversal Strategies: The introduction of sugammadex offers a revolutionary and fast method to reverse aminosteroid paralytics, improving recovery times and patient safety. However, its side effect profile, including allergic reactions and hormonal contraceptive interference, requires careful patient counseling and risk-benefit evaluation. Neostigmine remains a valuable alternative but demands careful co-administration with glycopyrrolate to counteract bradycardia, illustrating the importance of pharmacologic synergy and sequencing.

• Managing Postoperative Nausea and Vomiting (PONV): Dexamethasone and ondansetron are essential anti-emetics used at different stages, dexamethasone during induction and ondansetron near emergence, to reduce PONV, a common and distressing postoperative complication. The timing and patient-specific contraindications, such as QT prolongation risk with ondansetron, underscore the nuanced approach to supportive care.

• The Anesthesiologist as a Pharmacologic “Chef”: Max’s metaphor of selecting anesthetic drugs like a chef choosing ingredients highlights the artistry involved in anesthesia—blending multiple medications to create a balanced, safe, and effective anesthetic tailored to each patient’s unique needs. This perspective emphasizes the complexity and skill required in anesthesia practice beyond simple protocol adherence.